<DOC>
	<DOCNO>NCT00797160</DOCNO>
	<brief_summary>The aim study compare intubation condition among propofol remifentanil versus midazolam remifentanil premature neonates respiratory distress syndrome . At time , show group drug could let neonate residual sedation use surfactant ( possibility premature neonates readily extubated use surfactant ) .</brief_summary>
	<brief_title>Propofol Versus Midazolam Premedication Preterm Neonates With Respiratory Distress Syndrome ( RDS )</brief_title>
	<detailed_description>It demonstrate remifentanil , due short context-sensitive , interesting potential use premature neonates respiratory distress syndrome . Indeed , remifentanil allow adequate level sedation analgesia well rapid recovery discontinuation . The aim present study compare intubation condition among propofol remifentanil versus midazolam remifentanil premature neonates respiratory distress syndrome .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Gestational age 2834 wk Clinical radiological feature compatible respiratory distress syndrome require elective tracheal intubation surfactant therapy Hemodynamic stability tracheal intubation Signature ( parent ) consent form The presence major congenital malformation Birth weigh less 1000 g Previous use opioid sedative drug reason Previous tracheal intubation Hemodynamic instability indication tracheal intubation Refuse parent enroll neonate study protocol</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>2 Days</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>propofol</keyword>
	<keyword>midazolam</keyword>
	<keyword>neonate</keyword>
	<keyword>tracheal intubation</keyword>
</DOC>